14.04
-1.26(-8.24%)
Currency In USD
| Previous Close | 15.3 |
| Open | 15.15 |
| Day High | 15.18 |
| Day Low | 14.04 |
| 52-Week High | 69.97 |
| 52-Week Low | 6.76 |
| Volume | 717,660 |
| Average Volume | 532,016 |
| Market Cap | 179.54M |
| PE | 0.05 |
| EPS | 279.15 |
| Moving Average 50 Days | 17.16 |
| Moving Average 200 Days | 26.69 |
| Change | -1.26 |
If you invested $1000 in Tonix Pharmaceuticals Holding Corp. (TNXP) 10 years ago, it would be worth $0 as of February 21, 2026 at a share price of $14.04. Whereas If you bought $1000 worth of Tonix Pharmaceuticals Holding Corp. (TNXP) shares 5 years ago, it would be worth $0.02 as of February 21, 2026 at a share price of $14.04.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit
GlobeNewswire Inc.
Jan 30, 2026 12:00 PM GMT
TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study Unique sublingual formulation designed for bedtime dosing bypasses first-pass metabolism, optimizing parent-drug exposure during sleep
Tonix Pharmaceuticals to Present at Two Investor Conferences in January 2026
GlobeNewswire Inc.
Jan 06, 2026 12:00 PM GMT
BERKELEY HEIGHTS, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully integrated, commercial biotechnology company, announced today that Tonix management will present and host i
Tonix Pharmaceuticals Announces Pricing of $20.0 Million Registered Direct Offering
GlobeNewswire Inc.
Dec 29, 2025 12:57 PM GMT
CHATHAM, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase agr